Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages
Author(s) -
Tommaso Neri,
Cinzia Cordazzo,
Yuri Carmazzi,
Silvia Petrini,
Cristina Balìa,
Fabio Stefanelli,
Angela Amoruso,
Sandra Brunelleschi,
Maria Cristina Breschi,
Roberto Pedrinelli,
Pierluigi Paggiaro,
Alessandro Celi
Publication year - 2012
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvs125
Subject(s) - microparticle , tissue factor , chemistry , annexin , rosiglitazone , peroxisome proliferator activated receptor , phosphatidylserine , cd36 , pharmacology , receptor , microbiology and biotechnology , endocrinology , medicine , biology , apoptosis , biochemistry , coagulation , phospholipid , membrane , astrobiology
Microparticles are membrane vesicles shed by cells upon activation and/or apoptosis. Microparticles are involved in several processes, including blood coagulation and thrombosis. In addition to their role in the regulation of lipid metabolism, peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists exert other effects, both dependent on and independent of PPAR-γ activation. Some PPAR-γ agonists have been linked to an increased risk of thrombotic diseases. We aimed to investigate the potential role of PPAR-γ agonists on the generation of procoagulant microparticles by human monocytes/macrophages.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom